Nav: Home

Women caught in a pickle by their own immune systems

June 11, 2019

Women get autoimmune diseases, such as multiple sclerosis, lupus and rheumatoid arthritis eight times more than men do. On the other hand, women have a smaller risk of getting non-reproductive cancers such as melanoma, colon, kidney and lung cancer.

And while there are some exciting developments in cancer treatments, such as immunotherapies, research is showing that women are responding more favorably than men to this type of intervention.

So why is there such a big difference between women and men when it comes to human diseases?

An interdisciplinary team of scientists at Arizona State University believes it may have the answer.

In a paper published today in the scientific journal "Trends in Genetics," the team presents a new hypothesis to explain the phenomenon, setting the stage for novel research avenues focused specifically on treating autoimmune diseases and cancer.

"Until now, the differences between women and men in regards to human diseases have not been explained by existing theories," said Melissa Wilson, assistant professor with ASU's School of Life Sciences and senior author of the paper. "We are proposing a new theory called The Pregnancy Compensation Hypothesis.

"Basically, women's immune systems evolved to facilitate their survival during the presence of an immunologically invasive placenta and pregnancy, and compensate so they could also survive the assault of parasites and pathogens. But now, in modern, industrialized societies, women are not pregnant all the time so they don't have a placenta pushing back against the immune system. The changes in their reproductive ecology exacerbate the increased risk of autoimmune disease because immune surveillance is heightened. At the same time, we see a reduction in some diseases, like cancer," Wilson said.

Heini Natri, the lead author of the study and a postdoctoral scholar with the ASU Center for Evolution and Medicine, said because the immune system varies between the sexes, it should be considered when developing immunotherapies and other treatments.

"We think the Pregnancy Compensation Hypothesis can explain why there's a big sex difference in these diseases. Going forward, understanding the evolutionary origin of the sex bias in these diseases can help us better understand the mechanisms and particular pieces of the immune system we can target," said Natri. "Our goal is to actually make treatments better for everyone. We are realizing that cancer is different in men and women. In the study of most cancers and other diseases, and so far in the development of cancer treatments, that has not really been taken into account."

Effects of industrialization

Another factor that may exacerbate this situation is living a modern-day, urban lifestyle.

In industrialized communities, autoimmune diseases appear to occur at a much higher rate than in non-industrialized populations. The researchers believe the human immune system evolved expecting a given load of parasites. In the modern environment, exposure to those parasites has diminished so the immune system has fewer foreign targets. With this reduced load, the immune system attacks 'self.'

"There is a mismatch between the ancestral environment humans were adapted to, and the industrialized environment many people currently live in. In terms of an evolutionary timescale, our environment has changed incredibly fast," said Angela Garcia, also a postdoctoral research fellow with the center.

"We have also shifted from an active lifestyle to a sedentary one. We now have an overabundance of calories available, which potentially allows us to maintain excessive levels of hormones, including the female hormone estradiol. Maintaining such high levels of hormones may increase the chance of triggering autoimmune diseases," she said.

Future treatments

The researchers suggest that by framing future research within the Pregnancy Compensation Hypothesis, scientists could dive deeper into the characterization of genes, environmental context and the longitudinal history of people.

"We think this is more than a hypothesis. By using modern molecular biologic techniques in genetics and genomics, we can look at the differences between male and female immune systems, and between modern immune profiles and those in pre-industrial populations. By doing so, we may find new ways to prevent cancer and autoimmune diseases," Ken Buetow, a professor with the school and co-author of the study.

The researchers also suggest there are places where genes are regulated uniquely in males and females, as well as across environmental contexts.

"Going forward, we need to systematically collect environmental variables like pathogenic exposure, levels of stress and reproductive hormones, and parity. We have to understand these areas better," said Wilson.
-end-


Arizona State University

Related Cancer Articles:

Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
Radiotherapy for invasive breast cancer increases the risk of second primary lung cancer
East Asian female breast cancer patients receiving radiotherapy have a higher risk of developing second primary lung cancer.
More Cancer News and Cancer Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Rethinking Anger
Anger is universal and complex: it can be quiet, festering, justified, vengeful, and destructive. This hour, TED speakers explore the many sides of anger, why we need it, and who's allowed to feel it. Guests include psychologists Ryan Martin and Russell Kolts, writer Soraya Chemaly, former talk radio host Lisa Fritsch, and business professor Dan Moshavi.
Now Playing: Science for the People

#538 Nobels and Astrophysics
This week we start with this year's physics Nobel Prize awarded to Jim Peebles, Michel Mayor, and Didier Queloz and finish with a discussion of the Nobel Prizes as a way to award and highlight important science. Are they still relevant? When science breakthroughs are built on the backs of hundreds -- and sometimes thousands -- of people's hard work, how do you pick just three to highlight? Join host Rachelle Saunders and astrophysicist, author, and science communicator Ethan Siegel for their chat about astrophysics and Nobel Prizes.